BOD - 6M RESULTS FOR PERIOD ENDED 31/12/25 APPROVED

6M RECURRING PROFIT ABOVE €620M,
APPROX. ~€300M IN LAST QUARTER
PROPOSED DIVIDEND €0.63 (UP 13%¹)

In 6M:
WM: TFAs €115bn (up 8% YoY¹, stable in 3M)
with €2.6bn in NNM in AUM in 6M
CF: €4.9bn in new loans (up 12% YoY¹) with high profitability
Revenues: €1,786m (down 3% YoY¹), on growth in CF and INS with WM stable,
offsetting the reduction in CIB (from the outstanding levels posted in 2024)
CF up 6%1, INS up 14%¹, WM down 1%1, CIB down 20%¹
Cost/income ratio: 46% (up 3pp,¹ in part due to incentivization measures)
Cost of risk: 53 bps, with €164m in overlays remaining (€25m used in 6M)
Net profit: €623m (down 6% YoY¹) on a recurring basis,
€513m after ~€110m in net one-off items
Proposed DPS: €0.63 (up 13% YoY¹), payable April 2026

In 3M:
Recovery in revenues: €918m (up 6% QoQ²), with all income sources increasing
Net interest income up 1%² on growth in CF (up 3%²)
Fee income up 6%² driven by higher fees in WM (up 17%²)
Cost/income ratio: 47%
Cost of risk: 55 bps (with €13m in overlays used in 3M)
Net profit: ~€300m (down 6% QoQ¹) on a recurring basis,
€221m after ~€80m in net one-off items
CET1³ higher at 16.4% (up 130 bps vs June, up 60 bps QoQ²)
with 100% payout ratio and property revaluations (adding 70 bps in last 3M)

^{1  YoY chg: 6M to end-December 2025 vs 6M to end-December 2024.
2  QoQ: 3M to end-December 2025 vs 3M to end-September 2025.
3  CET1 fully loaded: 16.1% including the effects of CRR III fully-loaded (excluding FRTB).}